Last reviewed · How we verify
Treatment BY METROMIDAZOLE
Metronidazole is an antibiotic that works by stopping the growth of bacteria and protozoa.
Metronidazole is an antibiotic that works by stopping the growth of bacteria and protozoa. Used for Amoebiasis, Bacterial vaginosis, Gastrointestinal infections.
At a glance
| Generic name | Treatment BY METROMIDAZOLE |
|---|---|
| Sponsor | Assistance Publique Hopitaux De Marseille |
| Drug class | nitroimidazole antibiotic |
| Modality | Small molecule |
| Therapeutic area | Infectious diseases |
| Phase | Phase 3 |
Mechanism of action
It does this by inhibiting the synthesis of DNA and proteins in these microorganisms, ultimately leading to their death. This is achieved through the disruption of the bacterial cell's ability to produce thymidine, a nucleotide essential for DNA replication.
Approved indications
- Amoebiasis
- Bacterial vaginosis
- Gastrointestinal infections
- Pelvic inflammatory disease
- Perioperative prophylaxis
- Skin infections
- Trichomoniasis
Common side effects
- Abdominal pain
- Diarrhea
- Nausea
- Vomiting
- Headache
- Dizziness
- Taste disturbances
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Treatment BY METROMIDAZOLE CI brief — competitive landscape report
- Treatment BY METROMIDAZOLE updates RSS · CI watch RSS
- Assistance Publique Hopitaux De Marseille portfolio CI